Medicine Description eduropan 8mg
eduropan 8mg tablets is a medication belonging to the class of non-steroidal anti-inflammatory drugs (NSAIDs). The active ingredient, Lornoxicam, exerts its pharmacological effects by inhibiting cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. This inhibition leads to a decrease in the synthesis of prostaglandins, which are compounds responsible for mediating inflammation, pain, and fever. By reducing the levels of these inflammatory mediators, Lornoxicam effectively alleviates pain and decreases inflammation associated with various conditions, such as arthritis and musculoskeletal disorders. Additionally, this action contributes to its therapeutic efficacy in managing acute pain episodes, thus enhancing the overall quality of life for patients suffering from painful inflammatory conditions.
Indications and Uses of eduropan 8mg tablets
- Management of acute pain
- Relief of pain associated with osteoarthritis
- Symptomatic treatment of rheumatoid arthritis
- Management of postoperative pain
- Relief of pain in conditions such as tendinitis and bursitis
Side Effects of eduropan 8mg tablets
- Gastrointestinal discomfort
- Nausea
- Dizziness
- Headache
- Increased risk of cardiovascular events
- Renal impairment
- Allergic reactions
Storage and Handling
Store eduropan 8mg tablets in a cool, dry place, away from direct sunlight. Keep out of reach of children and do not use after the expiration date printed on the package.
Patient Advice and Precautions
Patients should take eduropan 8mg tablets with food to minimize gastrointestinal discomfort. It is essential to inform healthcare providers of any history of cardiovascular issues or gastrointestinal disorders prior to use. Avoid concurrent use with other NSAIDs or anticoagulants unless advised by a healthcare professional. Regular monitoring of renal function may be necessary for patients with pre-existing kidney conditions.